{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:15:16Z","timestamp":1777392916842,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40257-014-0096-2","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T09:33:15Z","timestamp":1411637595000},"page":"489-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Topical Therapy for Toenail Onychomycosis: An Evidence-Based Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanne","family":"Daigle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"issue":"9","key":"96_CR1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","volume":"133","author":"BE Elewski","year":"1997","unstructured":"Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol. 1997;133(9):1172\u20133.","journal-title":"Arch Dermatol."},{"issue":"10","key":"96_CR2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","volume":"36","author":"AK Gupta","year":"1997","unstructured":"Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada\u2013a multicenter survey of 2001 patients. Int J Dermatol. 1997;36(10):783\u20137.","journal-title":"Int J Dermatol."},{"issue":"5","key":"96_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2133.1995.tb02741.x","volume":"133","author":"H Heikkil\u00e4","year":"1995","unstructured":"Heikkil\u00e4 H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol. 1995;133(5):699\u2013703.","journal-title":"Br J Dermatol."},{"issue":"Suppl 39","key":"96_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1992.tb00005.x","volume":"126","author":"DT Roberts","year":"1992","unstructured":"Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol. 1992;126(Suppl 39):23\u20137.","journal-title":"Br J Dermatol."},{"key":"96_CR5","doi-asserted-by":"crossref","unstructured":"Gupta A, Nakrieko K-A. Molecular determination of mixed infections of dermatophytes and nondermatophyte moulds in individuals with onychomycosis. J Am Podiatr Med Assoc. 2014. (Epub ahead of print).","DOI":"10.7547\/13-030.1"},{"issue":"3","key":"96_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","volume":"11","author":"BE Elewski","year":"1998","unstructured":"Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11(3):415\u201329.","journal-title":"Clin Microbiol Rev."},{"issue":"2","key":"96_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clindermatol.2009.12.006","volume":"28","author":"O Welsh","year":"2010","unstructured":"Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol. 2010;28(2):151\u20139.","journal-title":"Clin Dermatol."},{"issue":"2 Pt 1","key":"96_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","volume":"41","author":"LA Drake","year":"1999","unstructured":"Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol. 1999;41(2 Pt 1):189\u201396.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"96_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073086","volume":"207","author":"JE Arrese","year":"2003","unstructured":"Arrese JE, Pi\u00e9rard GE. Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology. 2003;207(3):255\u201360.","journal-title":"Dermatology."},{"issue":"5","key":"96_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","volume":"31","author":"AK Gupta","year":"2013","unstructured":"Gupta AK, Paquet M, Simpson FC. Therapies for the treatment of onychomycosis. Clin Dermatol. 2013;31(5):544\u201354.","journal-title":"Clin Dermatol."},{"issue":"1","key":"96_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40257-013-0056-2","volume":"15","author":"DC S\u00e1 De","year":"2014","unstructured":"De S\u00e1 DC, Lamas APB, Tosti A. Oral therapy for onychomycosis: an evidence-based review. Am J Clin Dermatol. 2014;15(1):17\u201336.","journal-title":"Am J Clin Dermatol."},{"issue":"3","key":"96_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1468-3083.2011.04373.x","volume":"27","author":"BE Elewski","year":"2013","unstructured":"Elewski BE, Ghannoum MA, Mayser P, Gupta AK, Korting H-C, Shouey RJ, et al. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs. J Eur Acad Dermatol Venereol. 2013;27(3):287\u201394.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"96_CR13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","volume":"68","author":"BE Elewski","year":"2013","unstructured":"Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, et al. Efinaconazole 10\u00a0% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68(4):600\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"4 Suppl","key":"96_CR14","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","volume":"43","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8\u00a0% in the treatment of toenail onychomycosis. J Am Acad Dermatol. 2000;43(4 Suppl):S70\u201380.","journal-title":"J Am Acad Dermatol."},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/0926-9959(94)00076-C","volume":"4","author":"M Zaug","year":"1995","unstructured":"Zaug M. Amorolfine nail lacquer: clinical experience in onychomycosis. J Eur Acad Dermatol Venereol. 1995;4:S23\u201330.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"96_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10227-002-0137-y","volume":"7","author":"AK Gupta","year":"2003","unstructured":"Gupta AK, Ryder JE, Bluhm R, Johnson A, Summerbell RC. Onychomycosis: quality of studies. J Cutan Med Surg. 2003;7(4):312\u20136.","journal-title":"J Cutan Med Surg."},{"key":"96_CR17","unstructured":"US Food and Drug Administration. Drugs@FDA: FDA approved drug products (Tavaborole). Available from: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails . Accessed 14 July 2014."},{"issue":"7\u20138","key":"96_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1439-0507.1997.tb00227.x","volume":"40","author":"HC Korting","year":"1997","unstructured":"Korting HC, Grundmann-Kollmann M. The hydroxypyridones: a class of antimycotics of its own. Mycoses. 1997;40(7\u20138):243\u20137.","journal-title":"Mycoses."},{"issue":"7","key":"96_CR19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03164.x","volume":"23","author":"R Baran","year":"2009","unstructured":"Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V, et al. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol. 2009;23(7):773\u201381.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"3","key":"96_CR20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.jfas.2008.12.012","volume":"48","author":"DS Malay","year":"2009","unstructured":"Malay DS, Yi S, Borowsky P, Downey MS, Mlodzienski AJ. Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. J Foot Ankle Surg. 2009;48(3):294\u2013308.","journal-title":"J Foot Ankle Surg."},{"issue":"1","key":"96_CR21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1590\/S0365-05962012000100002","volume":"87","author":"S Schalka","year":"2012","unstructured":"Schalka S, Nunes S, Gomes Neto A. Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8\u00a0% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes. An Bras Dermatol. 2012;87(1):19\u201325.","journal-title":"An Bras Dermatol."},{"issue":"2","key":"96_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1346-8138.2009.00773.x","volume":"37","author":"A Shemer","year":"2010","unstructured":"Shemer A, Nathansohn N, Trau H, Amichai B, Grunwald MH. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study. J Dermatol. 2010;37(2):137\u20139.","journal-title":"J Dermatol."},{"issue":"2","key":"96_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199243020-00010","volume":"43","author":"JA Balfour","year":"1992","unstructured":"Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs. 1992;43(2):259\u201384.","journal-title":"Drugs."},{"issue":"6","key":"96_CR24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-2133.2011.10766.x","volume":"166","author":"R Dominicus","year":"2012","unstructured":"Dominicus R, Weidner C, Tate H, Kroon H-A. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome\u00ae) in patients with onychomycosis. Br J Dermatol. 2012;166(6):1360\u20132.","journal-title":"Br J Dermatol."},{"issue":"2","key":"96_CR25","first-page":"186","volume":"12","author":"EH Tschen","year":"2013","unstructured":"Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study. J Drugs Dermatol. 2013;12(2):186\u201392.","journal-title":"J Drugs Dermatol."},{"issue":"7","key":"96_CR26","first-page":"611","volume":"13","author":"AK Gupta","year":"2014","unstructured":"Gupta AK, Elewski BE, Sugarman JL, Kawabata H, Kang R, Pillai R, et al. The efficacy and safety of efinaconazole 10\u00a0% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials. J Drugs Dermatol. 2014;13(7):611\u20136.","journal-title":"J Drugs Dermatol."},{"issue":"6","key":"96_CR27","first-page":"313","volume":"53","author":"JB Montana","year":"1994","unstructured":"Montana JB, Scher RK. A double-blind, vehicle-controlled study of the safety and efficacy of fungoid tincture in patients with distal subungual onychomycosis of the toes. Cutis Cutan Med Pract. 1994;53(6):313\u20136.","journal-title":"Cutis Cutan Med Pract."},{"issue":"5","key":"96_CR28","first-page":"359","volume":"49","author":"MS Meyerson","year":"1992","unstructured":"Meyerson MS, Scher RK, Hochman LG, Cohen JL, Pappert AS, Holwell JE. Open-label study of the safety and efficacy of fungoid tincture in patients with distal subungual onychomycosis of the toes. Cutis Cutan Med Pract. 1992;49(5):359\u201362.","journal-title":"Cutis Cutan Med Pract."},{"key":"96_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/foot.2000.0653","volume":"11","author":"JC Ricketti","year":"2001","unstructured":"Ricketti JC. Terbinafine\/miconazole nitrate 2 % tincture compound for the treatment of onychomycosis. Foot. 2001;11:21\u20133.","journal-title":"Foot"},{"issue":"6","key":"96_CR30","first-page":"601","volume":"38","author":"DS Buck","year":"1994","unstructured":"Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract. 1994;38(6):601\u20135.","journal-title":"J Fam Pract."},{"key":"96_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.foot.2005.10.004","volume":"16","author":"KJ Davies","year":"2006","unstructured":"Davies KJ. Study to determine the efficacy of clotrimazole 1\u00a0% cream for the treatment of onychomycosis in association with the mechanical reduction of the nail plate. Foot. 2006;16:19\u201322.","journal-title":"Foot."},{"issue":"4","key":"96_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1365-3156.1999.00396.x","volume":"4","author":"TA Syed","year":"1999","unstructured":"Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Treatment of toenail onychomycosis with 2\u00a0% butenafine and 5\u00a0% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health. 1999;4(4):284\u20137.","journal-title":"Trop Med Int Health."},{"issue":"3","key":"96_CR33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2230.1988.tb01961.x","volume":"13","author":"RJ Hay","year":"1988","unstructured":"Hay RJ, Roberts DT, Doherty VR, Richardson MD, Midgley G. The topical treatment of onychomycosis using a new combined urea\/imidazole preparation. Clin Exp Dermatol. 1988;13(3):164\u20137.","journal-title":"Clin Exp Dermatol."},{"key":"96_CR34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1749-6632.1988.tb40457.x","volume":"544","author":"DT Roberts","year":"1988","unstructured":"Roberts DT, Hay RJ, Doherty VR, Richardson MD, Clayton YM. Topical treatment of onychomycosis using bifonazole 1\u00a0% urea\/40\u00a0% paste. Ann N Y Acad Sci. 1988;544:586\u20137.","journal-title":"Ann N Y Acad Sci."},{"issue":"11\u201312","key":"96_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1439-0507.1991.tb00867.x","volume":"34","author":"JM Torres-Rodr\u00edguez","year":"1991","unstructured":"Torres-Rodr\u00edguez JM, Madrenys N, Nicol\u00e1s MC. Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole. Mycoses. 1991;34(11\u201312):499\u2013504.","journal-title":"Mycoses."},{"issue":"1","key":"96_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/09546630510025950","volume":"16","author":"R Baran","year":"2005","unstructured":"Baran R, Coquard F. Combination of fluconazole and urea in a nail lacquer for treating onychomycosis. J Dermatol Treat. 2005;16(1):52\u20135.","journal-title":"J Dermatol Treat."},{"issue":"12","key":"96_CR37","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1055\/s-2008-1081338","volume":"74","author":"O Romero-Cerecero","year":"2008","unstructured":"Romero-Cerecero O, Zamilpa A, Jim\u00e9nez-Ferrer J, Rojas-Bribiesca G, Rom\u00e1n-Ramos R, Tortoriello J. Double-blind clinical trial for evaluating the effectiveness and tolerability of Ageratina pichinchensis extract on patients with mild to moderate onychomycosis. a comparative study with ciclopirox. Planta Med. 2008;74(12):1430\u20135.","journal-title":"Planta Med."},{"issue":"1","key":"96_CR38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jep.2009.08.007","volume":"126","author":"O Romero-Cerecero","year":"2009","unstructured":"Romero-Cerecero O, Rom\u00e1n-Ramos R, Zamilpa A, Jim\u00e9nez-Ferrer JE, Rojas-Bribiesca G, Tortoriello J. Clinical trial to compare the effectiveness of two concentrations of the Ageratina pichinchensis extract in the topical treatment of onychomycosis. J Ethnopharmacol. 2009;126(1):74\u20138.","journal-title":"J Ethnopharmacol."},{"issue":"3","key":"96_CR39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/myc.12019","volume":"56","author":"P Sipponen","year":"2013","unstructured":"Sipponen P, Sipponen A, Lohi J, Soini M, Tapanainen R, Jokinen JJ. Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study. Mycoses. 2013;56(3):289\u201396.","journal-title":"Mycoses."},{"issue":"10","key":"96_CR40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1439-0507.1989.tb02178.x","volume":"32","author":"J Faergemann","year":"1989","unstructured":"Faergemann J, Swanbeck G. Treatment of onychomycosis with a propylene glycol\u2013urea\u2013lactic acid solution. Mycoses. 1989;32(10):536\u201340.","journal-title":"Mycoses."},{"issue":"3","key":"96_CR41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7547\/87507315-89-3-124","volume":"89","author":"PS Wadhams","year":"1999","unstructured":"Wadhams PS, Griffith J, Nikravesh P, Chodosh D. Efficacy of a surfactant, allantoin, and benzalkonium chloride solution for onychomycosis. Preliminary results of treatment with periodic debridement. J Am Podiatr Med Assoc. 1999;89(3):124\u201330.","journal-title":"J Am Podiatr Med Assoc."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-014-0096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-014-0096-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-014-0096-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T23:03:24Z","timestamp":1717369404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-014-0096-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s40257-014-0096-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}